Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France.
Damien BotsenElise LepoixCamille MazzaMathilde BrasseurAnne GrangeFlorian SlimanoOlivier BouchéPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2019)
This study was undertaken to assess the previously unevaluated safety and feasibility of oxaliplatin-desensitization procedure add a French ambulatory cancer unit, which is a current topic in oncology. Our findings demonstrated that oxaliplatin-desensitization was safe and feasible in our ambulatory cancer unit. In routine practice, all these procedures are done on an inpatient basis starting at least the day before. Those results could change oncological practices in France and improve patients' quality of life and lower costs associated with inpatient administration.
Keyphrases
- papillary thyroid
- squamous cell
- end stage renal disease
- primary care
- palliative care
- blood pressure
- healthcare
- chronic kidney disease
- minimally invasive
- mental health
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- prostate cancer
- childhood cancer
- squamous cell carcinoma
- prognostic factors
- young adults
- acute care
- robot assisted
- patient reported